心脏植入性电子装置在无症状心房颤动检测与相关治疗中的作用
张璇,解玉泉
摘要(Abstract):
<正>1心脏植入性电子装置(cardiac implantable electronic devices,CIED)的介绍心脏植入性电子装置(cardiac implantable electronic devices,CIED)包括起搏器、植入式心律转复除颤器(implantable cardioverter defibrillation,ICD)、心脏再同步化治疗(cardiac resynchronization therapy,CRT)、植入式Holter及植入式循环记录仪(Loop recorder)等,是目前心内科在临床
关键词(KeyWords): 心脏植入性电子装置;心房颤动;卒中;抗凝治疗
基金项目(Foundation): 国家重点研发计划(2016YPC0206600);; 上海市科学技术委员会项目(15ZR1427400);; 上海交通大学科研项目(YG2014MS66)
作者(Author): 张璇,解玉泉
参考文献(References):
- [1]Tracy CM,Epstein AE,Darbar D,et al.2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities:a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines.J Thorac Cardiovasc Surg,2012,144(6):e127-e145.
- [2]Ponikowski P,Voors AA,Anker SD,et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.Rev Esp Cardiol(Engl Ed),2016,69(12):1167.
- [3]O'Gara PT,Kushner FG,Ascheim DD,et al.2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction:a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines.J Am Coll Cardiol,2013,61(4):e78-e140.
- [4]Andrade J,Khairy P,Dobrev D,et al.The clinical profile and pathophysiology of atrial fibrillation:relationships among clinical features,epidemiology,and mechanisms.Circ Res,2014,114(9):1453-1468.
- [5]Go AS,Mozaffarian D,Roger VL,et al.f Heart disease and stroke statistics-2014 update:a report from the American Heart Association.Circulation,2014,129(3):e28-e292.
- [6]Jorgensen HS,Nakayama H,Reith J,et al.Stroke recurrence:predictors,severity,and prognosis.The Copenhagen Stroke Study.Neurology,1997,48(4):891-895.
- [7]Dobreanu D,Svendsen JH,Lewalter T,et al.Current practice for diagnosis and management of silent atrial fibrillation:results of the European Heart Rhythm Association survey.Europace,2013,15(8):1223-1225.
- [8]Glotzer TV,Hellkamp AS,Zimmerman J,et al.Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke:report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial(MOST).Circulation,2003,107(12):1614-1619.
- [9]Daoud EG,Glotzer TV,Wyse DG,et al.Temporal relationship of atrial tachyarrhythmias,cerebrovascular events,and systemic emboli based on stored device data:a subgroup analysis of TRENDS.Heart Rhythm,2011,8(9):1416-1423.
- [10]Rostock T,Steven D,Lutomsky B,et al.Atrial fibrillation begets atrial fibrillation in the pulmonary veins:on the impact of atrial fibrillation on the electrophysiological properties of the pulmonary veins in humans.J Am Coll Cardiol,2008,51(22):2153-2160.
- [11]Nattel S,Harada M.Atrial remodeling and atrial fibrillation:recent advances and translational perspectives.J Am Coll Cardiol,2014,63(22):2335-2345.
- [12]Stambler BS,Ellenbogen KA,Orav EJ,et al.Predictors and clinical impact of atrial fibrillation after pacemaker implantation in elderly patients treated with dual chamber versus ventricular pacing.Pacing Clin Electrophysiol,2003,26(10):2000-2007.
- [13]Sanna T,Diener HC,Passman RS,et al.Cryptogenic stroke and underlying atrial fibrillation.N Engl J Med,2014,370(26):2478-2486.
- [14]Gladstone DJ,Spring M,Dorian P,et al.Atrial fibrillation in patients with cryptogenic stroke.N Engl J Med,2014,370(26):2467-2477.
- [15]Varma N,Epstein AE,Irimpen A,et al.Efficacy and safety of automatic remote monitoring for implantable cardioverterdefibrillator follow-up:the lumos-T safety reduces routine office device follow-up(TRUST)trial.Circulation,2010,122(4):325-332.
- [16]Crossley GH,Boyle A,Vitense H,et al.The CONNECT(clinical evaluation of remote notification to reduce time to clinical decision)trial:the value of wireless remote monitoring with automatic clinician alerts.J Am Coll Cardiol,2011,57(10):1181-1189.
- [17]Plummer CJ,Mc Comb JM.Detection of atrial fibrillation by permanent pacemakers:observations from the STOP AF trial.Card Electrophysiol Rev,2003,7(4):333-340.
- [18]Seet RC,Friedman PA,Rabinstein AA.Prolonged rhythm monitoring for the detection of occult paroxysmal atrial fibrillation in ischemic stroke of unknown cause.Circulation,2011,124(4):477-486.
- [19]Kaufman ES,Israel CW,Nair GM,et al.Positive predicitive value of device-detected atrial high-rate episodes at different rates and durations:an analysis from ASSERT.Heart Rhythm,2012,9(8):1241-1246.
- [20]Pollak WM,Simmons JD,Interian Jr A,et al.Clinical utility of intraatrial pacemaker stored electrograms to diagnose atrial fibrillation and flutter.Pacing Clin Electrophysiol,2001,24(4 Pt1):424-429.
- [21]Daoud EG,Glotzer TV,Wyse DG,et al.Temporal relationship of atrial tachyarrhythmias,cerebrovascular events,and systemic emboli based on stored device data:a subgroup analysis of TRENDS.Heart Rhythm,2011,8(9):1416-1423.
- [22]Healey JS,Connolly SJ,Gold MR,et al.Subclinical atrial fibrillation and the risk of stroke.N Engl J Med,2012,366(2):120-129.
- [23]Cabrera S,MercéJ,de Castro R,et al.Pacemaker clinic:an opportunity to detect silent atrial fibrillation and improve antithrombotic treatment.Europace,2011,13(11):1574-1579.
- [24]Glotzer TV,Daoud EG,Wyse DG,et al.The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk:the TRENDS study.Circ Arrhythm Electrophysiol,2009,2(5):474-480.
- [25]Chen-Scarabelli C,Scarabelli TM,Ellenbogen KA,et al.Devicedetected atrial fibrillation:what to do with asymptomatic patients?J Am Coll Cardiol,2015,65(3):281-294.
- [26]Kirchhof P,Benussi S,Kotecha D,et al.2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.Europace,2016,18(11):1609-1678.
- [27]January CT,Wann LS,Alpert JS,et al.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:Executive Summary:a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society.Circulation,2014,130(23):2071-2104.
- [28]De Cicco AE,Finkel JB,Greenspon AJ,et al.Clinical significance of atrial fibrillation detected by cardiac implantable electronic devices.Heart Rhythm,2014,11(4):719-724.
- [29]Healey JS,Martin JL,Duncan A,et al.Pacemaker-detected atrial fibrillation in patients with pacemakers:prevalence,predictors,and current use of oral anticoagulation.Can J Cardiol,2013,29(2):224-228.
- [30]Gulizia M,Mangiameli S,Orazi S,et al.A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease:the prevention investigation and treatment:a group for observation and research on atrial arrhythmias(PITAGORA).Am Heart J,2008,155(1):100-107.
- [31]Capuccia A,Botto G,Molon G,et al.The Drug and Pace Health cli Nical Evaluation(DAPHNE)study:a randomized trial comparing sotalol versus beta-blockers to treat symptomatic atrial fibrillation in patients with brady-tachycardia syndrome implanted with an antitachycardia pacemaker.Am Heart J,2008,156(2):373.e1-e8.